Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer. | J Cancer Res Clin Oncol | 2022 | 35767191 | PubTator, text mining | PubMed |
| Solid lipid nanoparticles to improve bioaccessibility and permeability of orally administered maslinic acid. | Drug Deliv | 2022 | 35762633 | PubTator, text mining | PubMed |
| Hyaluronan in pathophysiology of vascular diseases: specific roles in smooth muscle cells, endothelial cells, and macrophages. | Am J Physiol Cell Physiol | 2022 | 35759431 | PubTator, text mining | PubMed |
| Novel Brain-Stiffness-Mimicking Matrix Gel Enables Comprehensive Invasion Analysis of 3D Cultured GBM Cells. | Front Mol Biosci | 2022 | 35755807 | PubTator, text mining | PubMed |
| Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease. | Int J Mol Sci | 2022 | 35742845 | PubTator, text mining | PubMed |
| Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand? | Cancers (Basel) | 2022 | 35740657 | PubTator, text mining | PubMed |
| Targeting mitochondrial metabolism for metastatic cancer therapy. | Mol Carcinog | 2022 | 35723497 | PubTator, text mining | PubMed |
| KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry. | Medicine (Baltimore) | 2022 | 35713434 | PubTator, text mining | PubMed |
| Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. | Hepatol Commun | 2022 | 35712812 | PubTator, text mining | PubMed |
| Construction of long non-coding RNA- and microRNA-mediated competing endogenous RNA networks in alcohol-related esophageal cancer. | PLoS One | 2022 | 35704638 | PubTator, text mining | PubMed |
| Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes. | Front Genet | 2022 | 35692818 | PubTator, text mining | PubMed |
| Establishing an 8-gene immune prognostic model based on TP53 status for lung adenocarcinoma. | J Clin Lab Anal | 2022 | 35689561 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapies of Myeloid Leukaemia. | Int J Mol Sci | 2022 | 35682932 | PubTator, text mining | PubMed |
| Changes in the Transcriptome Caused by Mutations in the Ribosomal Protein uS10 Associated with a Predisposition to Colorectal Cancer. | Int J Mol Sci | 2022 | 35682850 | PubTator, text mining | PubMed |
| Bioengineering in salivary gland regeneration. | J Biomed Sci | 2022 | 35668440 | PubTator, text mining | PubMed |
| Adhesion molecules in multiple myeloma oncogenesis and targeted therapy. | Int J Hematol Oncol | 2022 | 35663420 | PubTator, text mining | PubMed |
| Selective isolation of hyaluronan by solid phase adsorption to silica. | Anal Biochem | 2022 | 35660507 | PubTator, text mining | PubMed |
| Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings. | Genes Chromosomes Cancer | 2022 | 35655404 | PubTator, text mining | PubMed |
| Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination. | Intern Med | 2022 | 35650138 | PubTator, text mining | PubMed |
| Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? | Chem Soc Rev | 2022 | 35642539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=26